Bioactive Compound Details

BioIDbio200428
NameVALDECOXIB
ChEMBL IDCHEMBL865
Molecular FormulaC16H14N2O3S
Molecular Weight314.37
Molecular Weight (Monoisotopic)314.0725
TypeSmall molecule
Max PhasePhase 4
Target IDTar81
Target NameNone
SynonymsBextra|NSC-759846|SC-65872|VALDECOXIB|VALDYN
SmilesCc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1
InchiInChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)
Inchi KeyLNPDTQAFDNKSHK-UHFFFAOYSA-N
Molecular SpeciesNEUTRAL
Targets215.0
Bioactivities995.0
Np Likeness Score-1.33
Records Key['3a (Valdecoxib)', '2', '2', 'SID144204991', 'Valdecoxib', 'VALDECOXIB', 'VLX', 'Valdecoxib', '5', 'VLX', 'VLX', 'VLX', 'VLX', 'VLX', 'VLX', '1', 'valdecoxib', 'SID49665731', '4, Valdecoxib', 'Valdecoxib', 'VLX', 'VLX', 'VLX', 'Valdecoxib', '4, valdecoxib', 'valdecoxib', 'VLX', '3892', '1', 'Valdecoxib', '5 (Valdecoxib)', 'VLX', 'VLX', 'VALDECOXIB', 'Valdecoxib', 'VLX', 'valdecoxib', 'VALDECOXIB', 'VALDECOXIB', 'SID26748964', 'VLX', 'VLX', 'VLX', 'VLX', 'VALDECOXIB', 'VLX', 'Valdecoxib', 'VLX', 'VLX', 'VLX', 'VLX', 'SID170465163', 'VLX', 'VLX', 'VLX', 'Valdecoxib', '303 (Valdecoxib)', '1', 'VALDECOXIB', 'Valdecoxib', 'SAM001246603', '5 (valdecoxib)', 'VALDECOXIB', 'VLX', 'Valdecoxib', 'VLX', 'VLX', 'Valdecoxib', '21', 'VLX', 'VLX', 'VLX', 'VLX', 'VLX', 'VLX', 'Valdecoxib', 'VALDECOXIB', 'VALDECOXIB', 'VALDECOXIB', 'MMV002260', 'VLX', 'VALDECOXIB', 'VLX', 'VLX', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', '20', 'VLX', 'VLX', 'VLX', 'VLX', 'VALDECOXIB', 'Valdecoxib', 'VALDECOXIB', 'Valdecoxib', 'COVC-2284008736', 'Valdecoxib', 'valdecoxib', 'VALDECOXIB']
Records Name['4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', 'SID144204991', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', 'VALDECOXIB', 'Valdecoxib', 'Valdecoxib', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', 'Valdecoxib', 'valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', 'valdecoxib', 'SID49665731', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide (Valdecoxib)', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', 'valdecoxib', 'valdecoxib', 'valdecoxib', '4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide', '4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide', '4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide', 'valdecoxib', None, 'valdecoxib', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', '4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide', 'valdecoxib', 'VALDECOXIB', 'Valdecoxib', 'Valdecoxib', 'valdecoxib', 'VALDECOXIB', 'VALDECOXIB', 'SID26748964', 'Valdecoxib', 'valdecoxib', 'Valdecoxib', 'valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'valdecoxib', 'valdecoxib', 'SID170465163', 'valdecoxib', 'Valdecoxib', '4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide', 'Valdecoxib', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', 'VALDECOXIB', 'Valdecoxib', 'C0164913', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', 'VALDECOXIB', 'Valdecoxib', '4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide', '4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide', 'valdecoxib', 'Valdecoxib', '4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide', 'Valdecoxib', 'Valdecoxib', 'valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'VALDECOXIB', 'VALDECOXIB', 'VALDECOXIB', 'C0088630', 'Valdecoxib', 'VALDECOXIB', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'Valdecoxib', 'valdecoxib', 'Valdecoxib', '4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide', 'Valdecoxib', 'VALDECOXIB', 'Valdecoxib', 'VALDECOXIB', 'Valdecoxib', 'VALDECOXIB', 'Valdecoxib', 'valdecoxib', 'VALDECOXIB']
Withdrawn FlagTrue
Orphan0

Molecular Structure

2D Molecular Structure